JPRN-UMIN000021569已完成2 期
A Phase II Study of Carbon-Ion Radiotherapy for Non-Squamous Cell Carcinoma of the Head and Neck - Carbon-Ion Therapy for Non-SCC of Head and Neck Tumor
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization0 个研究点目标入组 13 人开始时间: 2016年3月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 13
研究概览
简要总结
This study confirmed safety and efficacy comparable to those reported from prior facilities.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 80years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •A) Past history of radiotherapy for the target lesion B) Less than two weeks after the last administration of chemotherapy C) Active double cancer D) Active and intractable infection in the target lesion E) Metal devices in the target lesion which is not able to be removed F) Patient is not suitable for this study due to medical, psychological or the other reason
研究者
相似试验
已完成
2 期
A phase II study on the carbon-ion radiotherapy for T1c-T3N0M0 localized prostate cancerocalized prostate cancerJPRN-UMIN000020848Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization145
已完成
2 期
A phase II study of carbon-ion radiotherapy for patients with hepatocellular carcinoma developing multiple lesions or complicationsHepatocellular carcinomaJPRN-UMIN000026561Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization41
已完成
不适用
A phase II study of carbon-ion radiotherapy combined with anti-tumor agents for mucosal malignant melanoma of the head and neckmucosal malignant melanoma of the head and neckJPRN-UMIN000023182Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization2
已完成
2 期
A Phase II Clinical Trial of Carbon-ion Radiotherapy for Locally Advanced Pancreatic CancerJPRN-UMIN000030762Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization30
已完成
2 期
Phase II Clinical Trial of Carbon-Ion Radiotherapy with Longer Hormone Therapy for Clinical Stage T1b-T3N0M0 Prostate Cancerocalized prostate cancerJPRN-UMIN000021517Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization40
